Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Javier Adachi"'
Autor:
Issam I Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, Vivek Subbiah, Bilal Siddiqui, Arnaud Bayle, Robert Somer, Ana Fernández Cruz, Edward Gorak, Arvinder Bhinder, Nobuyoshi Mori, Nelson Hamerschlak, Samuel Shelanski, Tomislav Dragovich, Yee Elise Vong Kiat, Suha Fakhreddine, Abi Hanna Pierre, Roy F Chemaly, Victor Mulanovich, Javier Adachi, Jovan Borjan, Fareed Khawaja, Bruno Granwehr, Teny John, Eduardo Yepez Yepez, Harrys A Torres, Natraj Reddy Ammakkanavar, Marcel Yibirin, Cielito C Reyes-Gibby, Mala Pande, Noman Ali, Raniv Dawey Rojo, Shahnoor M Ali, Rita E Deeba, Patrick Chaftari, Takahiro Matsuo, Kazuhiro Ishikawa, Ryo Hasegawa, Ramón Aguado-Noya, Alvaro Garcia García, Cristina Traseira Puchol, Dong Gun Lee, Monica Slavin, Benjamin Teh, Cesar A Arias, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Dimitrios P Kontoyiannis, Alexandre E Malek, Anne-Marie Chaftari
Publikováno v:
eLife, Vol 12 (2023)
Background: In this international multicenter study, we aimed to determine the independent risk factors associated with increased 30 day mortality and the impact of cancer and novel treatment modalities in a large group of patients with and without c
Externí odkaz:
https://doaj.org/article/637c3f0430d841389b8f9a6f1c7c1fea
Autor:
Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundCOVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific antibodies found in CCP.Patients and MethodsPatients
Externí odkaz:
https://doaj.org/article/e8c03ca534d6409a85e0928d9fbecfca
Autor:
Denise Marie A. Francisco, Liangliang Zhang, Ying Jiang, Adilene Olvera, Javier Adachi, Eduardo Yepez Guevara, Samuel L. Aitken, Kevin W. Garey, Christine B. Peterson, Kim-Anh Do, Ryan Dillon, Engels N. Obi, Robert Jenq, Pablo C. Okhuysen
Publikováno v:
Infectious Diseases and Therapy. 12:209-225
Autor:
Patricia Mulanovich, Roy F Chemaly, Bruno Granwehr, Kelly McConn, Physician Assistant, Nina Patel, Issam I Raad, Javier Adachi
Publikováno v:
Open Forum Infectious Diseases. 9
Background Patients with COVID-19 and underlying malignancies, particularly those receiving immunosuppressive therapy, are at higher risk of severe COVID-19 disease. Our retrospective cohort study examines the outcomes of COVID-19 infection in patien
Autor:
Ray Y Hachem, Tarcila Datoguia, Bilal Siddiqui, Ana Fernandez Cruz, Nobuyoshi Mori, Suha Fakhreddine, Dong-Gun Lee, Edward Gorak, Robert Somer, Arvinder Bhinder, Samuel Shelanski, Tomislav Dragivich, Arnaud Bayle, Roy F Chemaly, Victor Mulonovich, Javier Adachi, Alexandre Malek, Monica Slavin, Ying Jiang, Anne-Marie Chaftari, Issam I Raad
Publikováno v:
Open Forum Infectious Diseases
Background Our objective was to describe the clinical course, risk factors and outcomes of patients infected with COVID-19 around the globe comparing cancer to non-cancer patients. Methods We conducted a retrospective cohort study of COVID-19 confirm
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S217
ENDOCARDITIS IN CANCER PATIENTS WITH AND WITHOUT THROMBOCYTOPENIA: PREVALENCE AND COMPLICATION RATES
Publikováno v:
Journal of the American College of Cardiology. 65:A1995